EUVIMEDEUVIMED entdecken
Open Access

Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy

Yuxia Zhou, Lu Liu, Bangming Jin, Yixuan Wu, Lifen Xu, Xuebing Chang, Laying Hu, Guifang Wang, Yali Huang, Lingyu Song, Tian Zhang, Yuanyuan Wang und 7 weitere

Diabetes · 01.05.2023 · 72 (5) · 611-626

DOI: 10.2337/db22-0680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 22.02.2023. Verfasst von Yuxia Zhou und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Hospital of Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Experimental, Sirtuin 3. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Young Talents Plan of Guizhou Medical University, Guizhou Provincial Science and Technology Projects, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ectopic lipid accumulation in renal tubules is closely related to the pathogenesis of diabetic kidney disease (DKD), and mitochondrial dysfunction is thought to play a key role in lipid accumulation. Therefore, maintaining mitochondrial homeostasis holds considerable promise as a therapeutic strategy for the treatment of DKD. Here, we report that the Meteorin-like (Metrnl) gene product mediates lipid accumulation in the kidney and has therapeutic potential for DKD. We confirmed the reduced expression of Metrnl in renal tubules, which was inversely correlated with DKD pathological changes in human patients and mouse models. Functionally, pharmacological administration of recombinant Metrnl (rMetrnl) or Metrnl overexpression could alleviate lipid accumulation and inhibit kidney failure. In vitro, rMetrnl or Metrnl overexpression attenuated palmitic acid–induced mitochondrial dysfunction and lipid accumulation in renal tubules accompanied by maintained mitochondrial homeostasis and enhanced lipid consumption. Conversely, shRNA-mediated Metrnl knockdown diminished the protective effect on the kidney. Mechanistically, these beneficial effects of Metrnl were mediated by the Sirt3-AMPK signaling axis to maintain mitochondrial homeostasis and through Sirt3-uncoupling protein-1 to promote thermogenesis, consequently alleviating lipid accumulation. In conclusion, our study demonstrates that Metrnl regulated lipid metabolism in the kidney by modulating mitochondrial function and is a stress-responsive regulator of kidney pathophysiology, which sheds light on novel strategies for treating DKD and associated kidney diseases. Article Highlights Metrnl is expressed in renal tubules and is reduced under diabetic conditions. The concentration of Metrnl in the kidney is correlated with lipid accumulation and serum creatinine. Metrnl-specific overexpression in the kidney or recombinant Metrnl administration alleviates renal injuries in diabetic mice. Metrnl regulates renal tubules lipid metabolism through Sirt3-AMPK/UCP1 signaling axis–mediated mitochondrial homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes Mellitus, ExperimentalSirtuin 3HumansMiceAnimalsAMP-Activated Protein KinasesMitochondriaLipidsHomeostasis

Substanzen

Sirtuin 3AMP-Activated Protein KinasesLipids

Autor:innen und Institutionen

  • Department of Nephrology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • International Scientific and Technological Cooperation Base of Pathogenesis and Drug Research on Common Major Diseases, Guizhou Medical University, Guiyang, China.
  • Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, China.
  • Department of Pathophysiology, Guizhou Medical University, Guiyang, China.
  • Department of Physiology, Guizhou Medical University, Guiyang, China.
  • School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Fujian, China.

ORCID-Profile: Bing Guo

Förderung

  • Young Talents Plan of Guizhou Medical University
  • Guizhou Provincial Science and Technology Projects
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Universities Young Science and Technology Talent Growth Project

Zitieren

APA

Zhou, Y., Liu, L., Jin, B., Wu, Y., Xu, L., Chang, X., Hu, L., Wang, G., Huang, Y., Song, L., Zhang, T., Wang, Y., Xiao, Y., Zhang, F., Shi, M., Liu, L., Wang, T., Yan, R., & Guo, B. (2023). Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy. Diabetes, 72(5), 611-626. https://doi.org/10.2337/db22-0680

Vancouver

Zhou Y, Liu L, Jin B, Wu Y, Xu L, Chang X, et al. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy. Diabetes. 2023;72(5):611-626. doi:10.2337/db22-0680

BibTeX
@article{Zhou2023,
  author = {Zhou, Yuxia and Liu, Lu and Jin, Bangming and Wu, Yixuan and Xu, Lifen and Chang, Xuebing and Hu, Laying and Wang, Guifang and Huang, Yali and Song, Lingyu and Zhang, Tian and Wang, Yuanyuan and Xiao, Ying and Zhang, Fan and Shi, Mingjun and Liu, Lingling and Wang, Tuanlao and Yan, Rui and Guo, Bing},
  title = {Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy},
  journal = {Diabetes},
  year = {2023},
  volume = {72},
  number = {5},
  pages = {611--626},
  doi = {10.2337/db22-0680}
}
Kostenlos starten →